According to the research report titled ‘Cardiovascular Devices Market Size By Device Type, By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global cardiovascular devices market is touted to expand at a considerable rate over 2021-2027.
 

Growing number of elderly individuals, prevalence of sedentary lifestyle, increasing government initiatives, and inclination towards minimally invasive procedures are driving global cardiovascular devices market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552130/
 

For those unversed, cardiac devices are used to enable the heart to beat with a normal rhythm. Cardiovascular devices such as endovascular grafts, coronary stents, angioplasty balloon catheters, and artificial heart valves can dramatically improve patients’ quality of life.
 

As cited by the Centers for Disease Control and Prevention (CDC), heart disease is one of the leading causes of death among women and men across the U.S. It is responsible for one in every four deaths, which amounts to approximately 655,000 people each year. Thus, increasing incidences of cardiac illnesses are likely to bolster industry valuation in the upcoming years.
 

Based on product type fragmentation of worldwide cardiovascular devices industry, radiofrequency cardiac ablator segment captured a major market share in 2020 and is expected to garner substantial returns over the forecast period, mainly due to availability of highly efficient atrial fibrillation treatments and development of advanced RF ablators by leading companies.
 

Moving on to end-user spectrum, the hospitals segment accounted for 55% industry share in 2020 and is reckoned to grow at a considerable rate over the forecast timeframe. This can be attributed to presence of well-equipped cardiac facilities as well as huge investment capacity of hospitals, which will attract a larger patient base.
 

In terms of geographical scope, Asia Pacific market is slated to garner a CAGR of 16.7% over the assessment period. This remarkable growth can be ascribed to rising incidences of CVDs among the elderly population, presence of several new entrants in the market, and extensive portfolio expansion by existing firms in the region.
 

Key players operating in global cardiovascular devices market sphere are MicroPort Scientific Corp., LivaNova plc, LifeTech Scientific Corp., Lepu Medical Technology (Beijing)Co. Ltd., Karl Storz SE & Co. KG., Japan Lifeline Co. Ltd., Getinge AB, CardioFocus Inc., Biotronik SE & Co. KG., Boston Scientific Corp., Biosense Webster Inc., AtriCure Inc., AngioDynamics Inc., and Abbott Laboratories among others.